Autopsy report · NCT04809649
SUBA-Itraconazole Therapy for Coccidioidomycosis Refractory or Intolerant to Fluconazole
Cause of deathStaffing, sites or logistics, also funding or business
“Sponsor is not proceeding with study due to budget cuts as a result of COVID-19.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 2
- Sponsor
- George R Thompson
- Sponsor type
- University, hospital or other
- Conditions
- Coccidioidomycosis; Valley Fever
- Interventions
- SUBA-itraconazole
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
“Sponsor decided not to pursue study” - Prospective Study To Assess The Safety And Effectiveness Of Tixel Treatment On Dry Eye Symptoms In Asian Patients
“Due to COVID19 adequate study monitoring wasn't possible by the Sponsor” - Manual Therapy/Exercises vs. Physiotherapy/Back School vs. Waiting List in Patients With Chronic Low Back Pain
“Sponsor did not want to continue the study.” - Randomized Controlled Study Comparing Colon Evaluation With The Pure-Vu System To A Standard Colonoscopy In Patients Who Are High Risk For Inadequate Bowel Preparation
“Sponsor has terminated study due to COVID-19 related concerns” - Liking Adaptation to Beverages of Varying Sweetness Levels After Prolonged Exposure
“Sponsor decision to stop study due to COVID-19 pandemic”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.